Press Release

Akebia Therapeutics to Present at the 2019 Cantor Global Healthcare Conference

September 24, 2019 at 8:00 AM EDT

 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 24, 2019-- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced that John P. Butler, President and Chief Executive Officer of Akebia, will present at the 2019 Cantor Global Healthcare Conference at 8:55 a.m. ET on Thursday, October 3, 2019 in New York City.

A live audio webcast and replay of the presentation will be available on the Company’s website at www.akebia.com.

 About Akebia Therapeutics 

 Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Source: Akebia Therapeutics, Inc.

Kristen K. Sheppard, Esq
VP, Investor Relations
ir@akebia.com 

 
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet